INTERNATIONAL WEX TECHNOLOGIES COMPLETES SAFETY STUDY.International Wex Technologies Inc. (CDNX CDNX See Canadian Venture Exchange (CDNX). :WXI.) has completed the clinical aspect of the multi-dose safety study for the two indications (opiate opiate /opi·ate/ (o´pe-it) 1. any drug derived from opium. 2. hypnotic (2). o·pi·ate n. 1. withdrawal treatment and pain management), in Canada. All of the data is has been analyzed in Toronto. In the area of neuro-bioscience, the company is focusing on the fields of drug addiction drug addiction or chemical dependency Physical and/or psychological dependency on a psychoactive (mind-altering) substance (e.g., alcohol, narcotics, nicotine), defined as continued use despite knowing that the substance causes harm. treatment, pain management and anesthesia. The company is developing products that contain a sodium channel Sodium channels (also known as "voltage-gated sodium channels") are integral membrane proteins that conduct sodium ions (Na+) through a cell's plasma membrane. Many of the ionotropic receptors are also able to conduct sodium ions. blocking compound and derivates extracted from natural organic substance using its proprietary manufacturing technology. Tetrodin can be found on the World Wide Web at http://www.wextech.ca. For more information, call 604/683-8880 or 800/722-7549. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion